Justin S. Keisel - 10 Feb 2026 Form 4 Insider Report for NU SKIN ENTERPRISES, INC. (NUS)

Role
EVP, President of Global Sales
Signature
/s/ Gregory Belliston as Attorney-in-Fact for Justin Keisel
Issuer symbol
NUS
Transactions as of
10 Feb 2026
Net transactions value
$0
Form type
4
Filing time
12 Feb 2026, 18:15:09 UTC
Previous filing
27 Feb 2025
Next filing
18 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Keisel Justin S EVP, President of Global Sales C/O NU SKIN ENTERPRISES, INC., 75 W CENTER STREET, PROVO /s/ Gregory Belliston as Attorney-in-Fact for Justin Keisel 12 Feb 2026 0002014791

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NUS Class A Common Stock Award $0 +2,910 +3.2% $0.000000 93,832 10 Feb 2026 Direct F1
transaction NUS Class A Common Stock Award $0 +34,500 +37% $0.000000 128,332 10 Feb 2026 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On February 27, 2024, the reporting person was granted restricted stock units, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On February 10, 2026, the performance criteria were met, resulting in the amount shown above becoming eligible for vesting.
F2 On February 26, 2025, the reporting person was granted restricted stock units, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On February 10, 2026, the performance criteria were met, resulting in the amount shown above becoming eligible for vesting.